Morgan Rand
Family · Shenandoah, TXNPI 1528709987
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,381, 9.5 times the $250 reported in 2022. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $23.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$936
- Novartis$523
- Johnson & Johnson$500
- ANI Pharmaceuticals, Inc.$441
- Amgen$283
- GSK$263
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,77797%
- Education$1313%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $936 |
| Novartis | 25 | $523 |
| Johnson & Johnson(2 entities) | 21 | $500 |
| ANI Pharmaceuticals, Inc. | 12 | $441 |
| Amgen | 9 | $283 |
| GSK | 8 | $263 |
| UCB, Inc. | 17 | $256 |
| Impulse Dynamics (USA) Inc. | 5 | $242 |
| Merck | 8 | $150 |
| Octapharma USA, Inc. | 1 | $150 |
| Pfizer | 7 | $142 |
| AstraZeneca | 5 | $103 |
| Lexicon Pharmaceuticals, Inc. | 6 | $103 |
| Seagen Inc. | 1 | $100 |
| Eisai Inc. | 5 | $90 |
| Boehringer Ingelheim | 5 | $86 |
| Genmab U.S., Inc. | 3 | $64 |
| Radius Health, Inc. | 2 | $54 |
| Myriad Genetic Laboratories, Inc. | 2 | $44 |
| Aurinia Pharma U.S., Inc. | 3 | $43 |
| Iovance Biotherapeutics, Inc. | 1 | $37 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Invivyd Inc | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Fresenius Kabi USA, LLC | 1 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $26 |
| Sandoz | 1 | $26 |
| Immunogen, Inc. | 1 | $24 |
| Agios Pharmaceuticals, Inc. | 1 | $24 |
| Bayer | 1 | $20 |
| Biocon Biologics Inc | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PURIFIED CORTROPHIN GEL$157
- OCTAGAM IMMUNE GLOBULIN (HUMAN)$150
- Rinvoq$125
- ZEJULA$111
- KRYSTEXXA$107
How this compares
$4,908 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xeljanz XrTofacitinib Citrate | 14 | $80,411 |
| Hydroxychloroquine Sulfate | 32 | $797 |
| MethotrexateMethotrexate Sodium | 41 | $663 |
| Leflunomide | 14 | $499 |
| Celecoxib | 13 | $461 |
| Prednisone | 27 | $114 |
Paid to pharmacies, not to this prescriber.
Other family in Shenandoah
- Jill CampbellShenandoah$182K
- Eliza CoddShenandoah$61K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.